Table 3.
Antibiotic susceptibility pattern of E. coli species isolates.
| Antimicrobial Agentes | Disk concentration | Diameter inhibition | %R | %I | %S | |
|---|---|---|---|---|---|---|
|
| ||||||
| Resistant | Susceptible | |||||
| Amikacin | 30 | ≤14 | ≥17 | 6.5 | - | 93.5 |
| Amp/Sulbactam | 10 | ≤11 | ≥15 | 35.5 | 20.5 | 31.8 |
| Ampicilin | 10 | ≤13 | ≥17 | 67.8 | - | 32.2 |
| Aztreonam | 30 | ≤15 | ≥22 | 38.7 | 6.5 | 54.8 |
| Cefazolin | 30 | ≤14 | ≥18 | 42 | 3.2 | 54.8 |
| Cefepime | 30 | ≤14 | ≥18 | 41.9 | - | 58.1 |
| Cefotaxime | 30 | ≤14 | ≥23 | 38.7 | - | 65.3 |
| Cefoxitin | 30 | ≤14 | ≥18 | 6.5 | 3.2 | 90.3 |
| Ceftazidime | 30 | ≤14 | ≥18 | 38.7 | - | 61.3 |
| Ceftriaxone | 30 | ≤13 | ≥21 | 35.5 | 3.2 | 61.3 |
| Ciprofloxacin | 5 | ≤15 | ≥21 | 41.9 | - | 58.1 |
| Doripenem | 8 | ≤13 | ≥21 | 3.2 | - | 96.8 |
| Ertapenem | 4 | ≤15 | ≥21 | 3.2 | - | 96.8 |
| Gentamicin | 10 | ≤12 | ≥15 | 22.6 | - | 77.4 |
| Meropenem | 10 | ≤13 | ≥16 | 6.5 | - | 93.5 |
| Nitrofurantoin | 300 | ≤14 | ≥17 | 6.5 | - | 93.5 |
| Pip/tazo | 100/10 | ≤17 | ≥21 | 22.5 | 6.5 | 71.3 |
| Piperacilin | 100 | ≤17 | ≥21 | 45.2 | - | 54.8 |
| Tobramycin | 10 | ≤12 | ≥15 | 19.3 | 9.7 | 71 |
| Trimet/sulfa | 0.25/23.7 | ≤10 | ≥16 | 50 | - | 50 |